Cannabis Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows – Cresco Labs (OTC:CRLBF), Green Thumb Industries (OTC:GTBIF) Read more
Biotechnology Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma – Eli Lilly and Co (NYSE:LLY) Read more
Cannabis Canopy Growth’s Big Step Toward Entry Into US Cannabis Market As DEA Rescheduling Looms – Constellation Brands (NYSE:STZ), Canopy Gwth (NASDAQ:CGC) Read more
Biotechnology German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Once Valued At Billions, 23andMe’s CEO Considers Privatization To Secure Company’s Future – 23andMe Holding (NASDAQ:ME) Read more
Eurozone EU Clears Microsoft’s $13B OpenAI Investment from Formal Probe: A Relief for Tech Giants – Microsoft (NASDAQ:MSFT) Read more
Biotechnology Why Is Vanda Pharmaceuticals Stock Trading Higher On Wednesday? – Vanda Pharma (NASDAQ:VNDA) Read more
Cannabis Cannabis Platform Vangst Acquires CannabizTeam’s Temp Staffing Division Amid Hiring Surge Read more
Biotechnology Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune Why Alpine Immune Sciences Stock Is Trading Higher Today? – Alpine Immune Sciences (NASDAQ:ALPN), Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing – Century Therapeutics (NASDAQ:IPSC) Read more
